---
figid: PMC4132784__zbc0371493260007
figtitle: Mechanism by which the PTEN-PI3K-AKT-MDM2 signaling axis exerts control
  over HIF1A degradation in cytoplasm under hypoxic conditions via the MDM2 E3 ligase
  and 26 S proteasome
organisms:
- Mus musculus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC4132784
filename: zbc0371493260007.jpg
figlink: /pmc/articles/PMC4132784/figure/F7/
number: F7
caption: Mechanism by which the PTEN-PI3K-AKT-MDM2 signaling axis exerts control over
  HIF1α degradation in cytoplasm under hypoxic conditions via the MDM2 E3 ligase and
  26 S proteasome. PI3K inhibitors block Ser166 phosphorylation of MDM2 resulting
  in cytoplasmic localization of MDM2; this new signaling pathway is therefore predicted
  to have therapeutic implications for the control of the HIF1α-VEGF axis in PI3K
  inhibitor cancer therapeutics.
papertitle: MDM2 Regulates Hypoxic Hypoxia-inducible Factor 1α Stability in an E3
  Ligase, Proteasome, and PTEN-Phosphatidylinositol 3-Kinase-AKT-dependent Manner.
reftext: Shweta Joshi, et al. J Biol Chem. 2014 Aug 15;289(33):22785-22797.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9596996
figid_alias: PMC4132784__F7
figtype: Figure
redirect_from: /figures/PMC4132784__F7
ndex: 6549ff0a-dee0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4132784__zbc0371493260007.html
  '@type': Dataset
  description: Mechanism by which the PTEN-PI3K-AKT-MDM2 signaling axis exerts control
    over HIF1α degradation in cytoplasm under hypoxic conditions via the MDM2 E3 ligase
    and 26 S proteasome. PI3K inhibitors block Ser166 phosphorylation of MDM2 resulting
    in cytoplasmic localization of MDM2; this new signaling pathway is therefore predicted
    to have therapeutic implications for the control of the HIF1α-VEGF axis in PI3K
    inhibitor cancer therapeutics.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - SLURP1
  - MDM2
  - PI3
  - VHL
  - CCL19
  - RBX1
  - CUL1
  - CUL2
  - CUL3
  - CUL4A
  - CUL4B
  - CUL5
  - CUL7
  - ARNT
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - EP300
  - TP53
  - TP63
  - TP73
  - Pdk1
  - Pdpk1
  - Akt1
  - Pik3r1
  - Pten
  - Ttn
  - Mdm2
  - Serpina1c
  - Vhl
  - Myl4
  - Ccl19
  - Ccl19-ps2
  - Ccl19-ps3
  - Rbx1
  - Arnt
  - Crebbp
  - Pag1
  - Cytip
  - Ep300
  - Trp53
  - Akt
  - IRSp53
  - IleRS
  - chico
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Mlc-c
  - Mlc1
  - elB
  - elA
  - Roc1a
  - cui
  - tgo
  - CBP
  - nej
  - eIF4E1
  - osa
  - p53
  - betaTub60D
  - hth
  - Proline
  - Tyrosine
  - Cancer
---
